-The Telegraph New Delhi: The World Health Organisation has announced a plan to approve generic versions of two expensive bio-therapeutic anti-cancer molecules in an effort to make them available to low and middle-income countries. It said it would invite manufacturers to submit applications for pre-qualification of biologically similar versions of rituximab, used to treat chronic lymphocytic leukaemia and non-Hodgkin's lymphoma, and trastuzumab, used to treat breast cancer. The pre-qualification process is a mechanism...

-Scroll.in Arsenic levels in water have been as high as 3,880 parts per billion in parts of the state. Pollution standards cite 50 parts per billion as harmful. It is a day like any other at Mahavir Cancer Sansthan. The driveway is lined with people who have travelled a long way to get to this charitable hospital in Patna. Families sit huddled, holding their bags close. The lobby is even more crowded,...

-Business Standard To make medicines cheaper, in another measure, govt added 200 drug formulations to NLEM list New Delhi/ Mumbai: Pharma companies may soon start wooing chemists as the Narendra Modi government plans to make it mandatory for doctors to prescribe pure-generic drugs, instead of branded generics as they do now. Though the plan was first announced in this year’s Budget, the prime minister spoke about it for the first time at a...

-The Times of India Cancer drugs, being the top focus for research and development, corner the lion's share of medicines launched globally, yet only a handful make it to developing countries like India. Only seven oncology drugs were introduced in India over five years (2010-2014), when nearly 50 breakthrough therapies were rolled out globally. The disparity in availability of oncology therapies becomes even more stark over a 10-year period (2006-2016), with not even...

-The Hindu Rise in cancer cases in Punjab can be attributed to indiscriminate use of agro-chemicals after the Green Revolution Bathinda: Lying on a bench at the Bathinda railway station, sexagenarian Gurjant Singh waits to board the Abohar-Jodhpur passenger train. He, however, is not the only one waiting. As the train chugs into the platform, people rush to claim their seats. Those who are unsuccessful settle down on the floor. Soon, the...